Yann Le Cam
European Organisation for Rare Diseases(FR)Maria College(US)
Publications by Year
Research Areas
Genomics and Rare Diseases, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Immunodeficiency and Autoimmune Disorders, BRCA gene mutations in cancer
Most-Cited Works
- → Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database(2019)1,718 cited
- → Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective(2017)188 cited
- → From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients(2015)186 cited
- → Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper(2014)114 cited
- → Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)(2017)104 cited
- → The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact(2017)89 cited
- → Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey(2024)87 cited
- → Progressive enlargement of filtrations with initial times(2009)71 cited
- → Involvement of Patient Organisations in Research and Development of Orphan Drugs for Rare Diseases in Europe(2012)65 cited
- → Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)(2021)52 cited